Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.

CI Financial Announces Filing and Mailing of Circular for Special Meeting to Approve Plan of Arrangement with Mubadala Capital ...

New U.S. Senator Jim Justice has earned a reputation for dodging fines, ignoring court orders, breaking contracts, and paying ...

Tiger Global-backed Innovacer, healthcare-focused software-as-a-service startup (SaaS), has secured $275 million in a ...

The deal counter is buzzing with new funding rounds across sectors. This and more in todays ETtech Morning Dispatch.

Light Horse Therapeutics is off to the races, rounding up a $62 million series A and tacking on a Novartis partnership that ...

Emirates Global Aluminium has signed a three-year agreement to be Abu Dhabi Sustainability Week (ADSW) Associate Partner. <li ...

U.S. law firm Skadden, Arps, Slate, Meagher & Flom on Thursday said it has opened an office in Abu Dhabi, following other ...

On Wednesday, New York-headquartered Focus Financial Partners announced plans to make Cardinal Point, which it acquired in ...

Healthcare-focused SaaS firm Innovaccer Inc. has secured $275 million in funding from investors including B Capital Group and ...

The last round in 2021 valued the healthcare technology firm at $3.2 billion, more than doubling its valuation from $1.3 ...

Light Horse Therapeutics Inc., a developer of first-in-class small molecule therapeutics, today announced a $62 million Series A financing. The financing was led by founding investor Versant Ventures ...